Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-06-21 4:05 pm Purchase | 13G | Perceptive Capital Solutions Corp PCSC | COMMODORE CAPITAL LP | 750,000 7% | 750,000![]() (New Position) | View |
2024-04-19 4:05 pm Purchase | 13G | Perspective Therapeutics Inc. CATX | COMMODORE CAPITAL LP | 38,906,673 6.6% | 38,906,673![]() (New Position) | View |
2024-03-21 4:05 pm Purchase | 13G | Mind Medicine (MindMed) Inc. MNMD | COMMODORE CAPITAL LP | 5,833,333 8.3% | 5,833,333![]() (New Position) | View |
2024-02-14 4:10 pm Purchase | 13G | Vera Therapeutics Inc. VERA | COMMODORE CAPITAL LP | 5,450,000 12.3% | 448,217![]() (+8.96%) | View |
2024-02-14 4:05 pm Sale | 13G | IMMUNIC INC. IMUX | COMMODORE CAPITAL LP | 0 0% | -2,873,563![]() (Position Closed) | View |
2024-02-14 4:05 pm Purchase | 13G | Adverum Biotechnologies Inc. ADVM | COMMODORE CAPITAL LP | 10,000,000 9.9% | 3,841,859![]() (+62.39%) | View |
2024-02-14 4:05 pm Purchase | 13G | Cogent Biosciences Inc. COGT | COMMODORE CAPITAL LP | 6,172,086 7.1% | 1,246,086![]() (+25.30%) | View |
2024-02-14 4:05 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | COMMODORE CAPITAL LP | 0 0% | -5,738,500![]() (Position Closed) | View |
2024-02-14 4:05 pm Unchanged | 13G | Ambrx Biopharma Inc. AMAM | COMMODORE CAPITAL LP | 0 0% | 0 (Unchanged) | View |
2024-02-14 4:05 pm Purchase | 13G | Cabaletta Bio Inc. CABA | COMMODORE CAPITAL LP | 1,900,000 4.4% | 441,633![]() (+30.28%) | View |
2024-02-14 4:05 pm Purchase | 13G | Celcuity Inc. CELC | COMMODORE CAPITAL LP | 2,492,886 9.9% | 235,474![]() (+10.43%) | View |
2024-02-14 4:05 pm Sale | 13G | SOLENO THERAPEUTICS INC SLNO | COMMODORE CAPITAL LP | 700,000 2.3% | -185,741![]() (-20.97%) | View |
2024-02-14 4:05 pm Purchase | 13G | SPYRE THERAPEUTICS, INC SYRE | COMMODORE CAPITAL LP | 1,934,084 5.4% | 100,000![]() (+5.45%) | View |
2024-02-14 4:05 pm Purchase | 13G | Enliven Therapeutics Inc. ELVN | COMMODORE CAPITAL LP | 2,901,816 7% | 819,693![]() (+39.37%) | View |
2024-02-14 4:05 pm Purchase | 13G | Merus N.V. MRUS | COMMODORE CAPITAL LP | 4,747,373 8.2% | 2,014,806![]() (+73.73%) | View |
2024-02-14 4:05 pm Purchase | 13G | SAB Biotherapeutics Inc. SABS | COMMODORE CAPITAL LP | 1,831,746 3.5% | 1,831,746![]() (New Position) | View |
2024-02-14 4:05 pm Sale | 13G | Viridian Therapeutics Inc. VRDN | COMMODORE CAPITAL LP | 1,924,074 3.7% | -96,092![]() (-4.76%) | View |
2024-02-14 4:05 pm Purchase | 13G | Vera Therapeutics Inc. VERA | COMMODORE CAPITAL LP | 5,001,783 11.3% | 2,658,926![]() (+113.49%) | View |
2024-01-19 4:05 pm Purchase | 13G | Adicet Bio Inc. ACET | COMMODORE CAPITAL LP | 4,250,000 9.8% | 4,250,000![]() (New Position) | View |
2023-12-22 4:05 pm Purchase | 13G | C4 Therapeutics Inc. CCCC | COMMODORE CAPITAL LP | 3,800,000 7.7% | 3,800,000![]() (New Position) | View |